181 related articles for article (PubMed ID: 37810997)
1. Engineered Extracellular Vesicle-Based Therapies for Valvular Heart Disease.
Salazar-Puerta AI; Kordowski M; Cuellar-Gaviria TZ; Rincon-Benavides MA; Hussein J; Flemister D; Mayoral-Andrade G; Barringer G; Guilfoyle E; Blackstone BN; Deng B; Zepeda-Orozco D; McComb DW; Powell H; Dasi LP; Gallego-Perez D; Higuita-Castro N
Cell Mol Bioeng; 2023 Aug; 16(4):309-324. PubMed ID: 37810997
[TBL] [Abstract][Full Text] [Related]
2. Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis.
Blaser MC; Buffolo F; Halu A; Turner ME; Schlotter F; Higashi H; Pantano L; Clift CL; Saddic LA; Atkins SK; Rogers MA; Pham T; Vromman A; Shvartz E; Sukhova GK; Monticone S; Camussi G; Robson SC; Body SC; Muehlschlegel JD; Singh SA; Aikawa M; Aikawa E
Circulation; 2023 Aug; 148(8):661-678. PubMed ID: 37427430
[TBL] [Abstract][Full Text] [Related]
3. Telocytes-derived extracellular vesicles alleviate aortic valve calcification by carrying miR-30b.
Yang R; Tang Y; Chen X; Yang Y
ESC Heart Fail; 2021 Oct; 8(5):3935-3946. PubMed ID: 34165260
[TBL] [Abstract][Full Text] [Related]
4. New calcification model for intact murine aortic valves.
Kruithof BPT; van de Pol V; Los T; Lodder K; Mousavi Gourabi B; DeRuiter MC; Goumans MJ; Ajmone Marsan N
J Mol Cell Cardiol; 2021 Jul; 156():95-104. PubMed ID: 33744308
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls.
Poggio P; Grau JB; Field BC; Sainger R; Seefried WF; Rizzolio F; Ferrari G
J Cell Physiol; 2011 Aug; 226(8):2139-49. PubMed ID: 21520066
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous multi-laminar tissue constructs as a platform to evaluate aortic valve matrix-dependent pathogenicity.
Monroe MN; Nikonowicz RC; Grande-Allen KJ
Acta Biomater; 2019 Oct; 97():420-427. PubMed ID: 31362141
[TBL] [Abstract][Full Text] [Related]
8. Human and porcine aortic valve endothelial and interstitial cell isolation and characterization.
Nehl D; Goody PR; Maus K; Pfeifer A; Aikawa E; Bakthiary F; Zimmer S; Nickenig G; Jansen F; Hosen MR
Front Cardiovasc Med; 2023; 10():1151028. PubMed ID: 37408661
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease.
Dayawansa NH; Baratchi S; Peter K
Front Cardiovasc Med; 2022; 9():783543. PubMed ID: 35355968
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in aortic valve hemostatic protein regulation.
Balaoing LR; Post AD; Liu H; Minn KT; Grande-Allen KJ
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):72-80. PubMed ID: 24177329
[TBL] [Abstract][Full Text] [Related]
12. IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease.
Yang Z; Zhang J; Zhu Y; Zhang C; Li G; Liu S; Du J; Han Y; You B
Biochem Biophys Res Commun; 2023 Sep; 672():145-153. PubMed ID: 37354607
[TBL] [Abstract][Full Text] [Related]
13. Procoagulant effect of extracellular vesicles in patients after transcatheter aortic valve replacement or transcatheter aortic valve replacement with percutaneous coronary intervention.
Chi H; Shao Y; Xie F; Zhang J; Zhang G; Jiang G; Tong D; Li J
J Thromb Thrombolysis; 2023 Aug; 56(2):264-274. PubMed ID: 37284999
[TBL] [Abstract][Full Text] [Related]
14. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
[TBL] [Abstract][Full Text] [Related]
15. Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells.
Tagzirt M; Rosa M; Corseaux D; Vincent F; Vincentelli A; Daoudi M; Jashari R; Staels B; Van Belle E; Susen S; Dupont A
J Thorac Cardiovasc Surg; 2023 Nov; 166(5):e377-e389. PubMed ID: 36182586
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo assessment of valve thickness/calcification of patients with calcific aortic stenosis in relation to in vivo clinical outcomes.
Cheng CL; Chang HH; Huang PJ; Wang WC; Lin SY
J Mech Behav Biomed Mater; 2017 Oct; 74():324-332. PubMed ID: 28651163
[TBL] [Abstract][Full Text] [Related]
18. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
